Long-term day-case treatment of peripheral neuromuscular disease with intravenous immunoglobulin: The practice of a regional day-case service in Preston, Lancashire

Abstract

Neuromuscular disease is one of the most common indications for the use of intravenous immunoglobulin (IVIG). We describe practical aspects of IVIG administration and dosing in long-term treatment, as well as the setting up of a day-case service in a regional neurology unit to provide a streamlined patient experience. An audit of the safety of IVIG administration and patient satisfaction during implementation supported the fact that this is a relatively safe treatment. Standardised assessment methods have been used both to monitor treatment effect and to provide the necessary outcome measures for Department of Health (DOH) monitoring of IVIG use. © Royal College of Physicians, 2013.